Articles - ASCVD & Lipidology Knowledge Hub

This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.

Confirm
  • Share

  • Stay up to date
  • Home
  • Topics
    • Acute Coronary Syndrome
    • Alirocumab
    • Apolipoprotein B
    • ASCVD
    • Aspirin
    • Atherosclerosis
    • Bempedoic acid
    • Cholesterol
    • Congresses
    • Coronary artery disease
    • CVD
    • CVD Risk Factor
    • Dyslipidemia
    • Evolocumab
    • Ezetimibe
    • Familial hypercholesterolemia
    • Guidelines
    • High-density lipoprotein
    • Hypercholesterolemia
    • Inclisiran
    • Influenza
    • Lipids
    • Lipoprotein (a)
    • Low-density lipoprotein
    • Low-density Lipoprotein Cholesterol
    • Myocardial Infarction
    • PCSK9
    • Pediatric Population
    • Short interfering RNA (siRNA)
    • Statin
    • Trials
    • Triglycerides
    • Vaccination
  • Webinars
  • Videos
  • Infographics
  • Articles
  • Case Studies
  • Faculty
  • Stay up to date

Aspirin Articles

  • Articles

    Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes

    Lacaze P, Bakshi A, Riaz M, et al.

    Journal: 

    J Am Coll Cardiol

    First published: October 4, 2022  DOI: 10.1016/j.jacc.2022.07.027

    View
    • Share

  • Articles

    Lp(a): Are Antithrombotic Therapies the Key to Event Reduction?

    Devesa A, Ibanez B, Fuster V

    Journal: 

    J Am Coll Cardiol

    First published: October 4, 2022  DOI: 10.1016/j.jacc.2022.08.722

    View
    • Share

  • Articles

    Rivaroxaban and aspirin vs. aspirin alone in Asian compared with non-Asian patients with chronic coronary artery disease or peripheral arterial disease: the COMPASS trial

    Hori M, Zhu J, Liang Y, et al.

    Journal: 

    Eur Heart J

    First published: June 25, 2022  DOI: 10.1093/eurheartj/ehac309

    View
    • Share

  • Articles

    Comparative Effectiveness of Aspirin Dosing in Cardiovascular Disease

    Jones WS, Mulder H, Wruck LM, et al.

    Journal: 

    N Engl J Med

    First published: May 27, 2022  DOI: 10.1056/NEJMoa2102137

    View
    • Share

  • Articles

    Aspirin Use to Prevent Cardiovascular Disease – US Preventive Services Task Force Recommendation Statement

    US Preventive Services Task Force

    Journal: 

    JAMA

    First published: April 26, 2022  DOI: 10.1001/jama.2022.4983

    View
    • Share

How would you rate this content?

  • © John Wiley & Sons, Ltd. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Stay up to date
  • Cookie Preferences
  • This Knowledge Hub is supported by Novartis.
Clinical Cardiology